4th International Consensus Conference: Primary Systemic Treatment in the Management of Operable Breast Cancer: Toward the Rapid Assessment of Therapy EfficacyBOTTINI, Alberto; BERRUTI, Alfredo; GENERALI, Daniele et al.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, issn 1052-6773, 101 p.Conference Proceedings

Mechanisms of Resistance to HER2 Target TherapyTORTORA, Giampaolo.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 95-98, issn 1052-6773, 4 p.Conference Paper

Neoadjuvant Chemotherapy and Targeted Therapies: a Promising StrategyMETZGER-FILHO, Otto; DE AZAMBUJA, Evandro.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 116-119, issn 1052-6773, 4 p.Conference Paper

kConFab: A Familial Breast Cancer Consortium Facilitating Research and Translational OncologyTHORNE, Heather; MITCHELL, Gillian; FOX, Stephen et al.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 79-81, issn 1052-6773, 3 p.Conference Paper

Metabolic bone disease induced by prostate cancer: Rationale for the use of bisphosphonatesBERRUTI, Alfredo; DOGLIOTTI, Luigi; TUCCI, Marcello et al.The Journal of urology. 2001, Vol 166, Num 6, pp 2023-2031, issn 0022-5347Article

Biomarkers Predicting Clinical Benefit: Fact or Fiction?GUARNERI, Valentina; BARBIERI, Elena; CONTE, Pierfranco et al.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 63-66, issn 1052-6773, 4 p.Conference Paper

Neoadjuvant Chemotherapy: Early Response as a Guide for Further Treatment: Clinical, Radiological, and BiologicalUNTCH, Michael; VON MINCKWITZ, Gunter.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 138-141, issn 1052-6773, 4 p.Conference Paper

Bridging the Gap Between Translational Research and Clinical ApplicationMILLER, William R; LARIONOV, Alexey A.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 134-137, issn 1052-6773, 4 p.Conference Paper

Intermediate Endpoints of Primary Systemic Therapy in Breast Cancer PatientsBERRUTI, Alfredo; GENERALI, Daniele; BERTAGLIA, Valentina et al.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 142-146, issn 1052-6773, 5 p.Conference Paper

Molecular Oncology and the Neoadjuvant Setting: the Perfect Blend for Treatment Personalization and Clinical Trial DesignGENERALI, Daniele; BERRUTI, Alfredo; BOTTINI, Alberto et al.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 67-70, issn 1052-6773, 4 p.Conference Paper

Gemcitabine and Protracted 5-Fluorouracil Infusion as Third-line Chemotherapy in Refractory Colorectal Cancer PatientsBITOSSI, Raffaella; SCULLI, Carla Maria; DOGLIOTTI, Luigi et al.Anticancer research. 2008, Vol 28, Num 5B, pp 3055-3060, issn 0250-7005, 6 p.Article

Gemcitabine plus cisplatin versus gemcitabine plus carboplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium: Results of a randomized phase 2 trialDOGLIOTTI, Luigi; CARTENI, Giacomo; SIENA, Salvatore et al.European urology. 2007, Vol 52, Num 1, pp 134-141, issn 0302-2838, 8 p.Article

Regulation of hepatocyte growth factor activator inhibitor 2 by hypoxia in breast cancerGENERALI, Daniele; FOX, Stephen B; CAMPO, Leticia et al.Clinical cancer research. 2007, Vol 13, Num 2, pp 550-558, issn 1078-0432, 9 p., 1Article

Feasibility of 21-day continuous infusion of epirubicin in hormone-refractory prostate cancer patientsBERRUTI, Alfredo; MOSCA, Alessandra; DOGLIOTTI, Luigi et al.Anticancer research. 2005, Vol 25, Num 6C, pp 4475-4479, issn 0250-7005, 5 p.Article

Background to and management of treatment-related bone loss in prostate cancerBERRUTI, Alfredo; TUCCI, Marcello; TERRONE, Carlo et al.Drugs & aging. 2002, Vol 19, Num 12, pp 899-910, issn 1170-229X, 12 p.Article

Effects of the somatostatin analog lanreotide on the circulating levels of chromogranin-A, prostate-specific antigen, and insulin-like growth factor-I in advanced prostate cancer patientsBERRUTI, Alfredo; DOGLIOTTI, Luigi; MOSCA, Alessandra et al.The Prostate. 2001, Vol 47, Num 3, pp 205-211, issn 0270-4137Article

Irinotecan and chronomodulated infusion of 5-fluorouracil and folinic acid in the treatment of patients with advanced colorectal carcinoma a Phase I studyGARUFI, Carlo; DOGLIOTTI, Luigi; D'ATTINO, Rita M et al.Cancer. 2001, Vol 91, Num 4, pp 712-720, issn 0008-543XArticle

Strategies to Translate Preclinical Information to Breast Cancer Patient BenefitDAIDONE, Maria Grazia; ZAFFARONI, Nadia; CAPPELLETTI, Vera et al.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 55-59, issn 1052-6773, 5 p.Conference Paper

Phosphorylated ERa, HIF-1α, and MAPK Signaling As Predictors of Primary Endocrine Treatment Response and Resistance in Patients With Breast CancerGENERALI, Daniele; BUFFA, Francesca M; PAPOTTI, Mauro et al.Journal of clinical oncology. 2009, Vol 27, Num 2, pp 227-234, issn 0732-183X, 8 p.Article

The circadian rhythm of biochemical markers of bone resorption is normally synchronized in breast cancer patients with bone lytic metastases independently of tumor loadGENERALI, Daniele; BERRUTI, Alfredo; BOTTINI, Alberto et al.Bone (New York, NY). 2007, Vol 40, Num 1, pp 182-188, issn 8756-3282, 7 p.Article

Hypoxia-lnducible factor-1α expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancerGENERALI, Daniele; BERRUTI, Alfredo; GANDOLFI, Valeria et al.Clinical cancer research. 2006, Vol 12, Num 15, pp 4562-4568, issn 1078-0432, 7 p.Article

Changes in microvessel density as assessed by CD34 antibodies after primary chemotherapy in human breast cancerBOTTINI, Alberto; BERRUTI, Alfredo; SCARATTI, Lorena et al.Clinical cancer research. 2002, Vol 8, Num 6, pp 1816-1821, issn 1078-0432Article

Time to progression in metastatic breast cancer patients treated with epirubicin is not improved by the addition of either cisplatin or lonidamine: Final results of a phase iii study with a factorial designBERRUTI, Alfredo; BITOSSI, Raffaella; LORUSSO, Vito et al.Journal of clinical oncology. 2002, Vol 20, Num 20, pp 4150-4159, issn 0732-183X, 10 p.Article

Metastatic and Locally Advanced Pancreatic Endocrine Carcinomas: Analysis of Factors Associated With Disease ProgressionPANZUTO, Francesco; BONINSEGNA, Letizia; DELLE FAVE, Gianfranco et al.Journal of clinical oncology. 2011, Vol 29, Num 17, pp 2372-2377, issn 0732-183X, 6 p.Article

The HER2 World: Better Treatment Selection for Better OutcomeTAGLIABUE, Elda; CAMPIGLIO, Manuela; PUPA, Serenella M et al.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 82-85, issn 1052-6773, 4 p.Conference Paper